Chugai Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Chugai Pharmaceutical Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Chugai Pharmaceutical Co Ltd Strategy Report
- Understand Chugai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Chugai Pharmaceutical Catalyst Calendar
Proactively evaluate Chugai Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Chugai Pharmaceutical Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
13 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
06 Sep 2019 | Phase II/III Trial Completion | Chugai Pharmaceutical Co Ltd; Duke Clinical Research Institute; F. Hoffmann-La Roche Ltd; PTC Therapeutics Inc; Spinal Muscular Atrophy Foundation; Syneos Health Inc | 4519; PTCT; ROG; SYNH | risdiplam | Central Nervous System | Spinal Muscular Atrophy (SMA) | Company Press Release |
31 Aug 2019 | Phase I Trial Completion | Chugai Pharmaceutical Co Ltd; F. Hoffmann-La Roche Ltd | 4519; ROG | balovaptan | Central Nervous System | Pervasive Developmental Disorder (PDD) | Clinical Trial Registry |
31 Aug 2019 | Phase I Trial Completion | Chugai Pharmaceutical Co Ltd; F. Hoffmann-La Roche Ltd | 4519; ROG | ralmitaront | Central Nervous System | Psychiatric Disorders | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer